Infantile infection and antibiotic exposure in association with pediatric psoriasis development: A nationwide nested case-control study - 13/01/21
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Abstract |
Background |
Microbiol dysbiosis and antibiotic exposure have been implicated in the pathogenesis of pediatric inflammatory diseases.
Objectives |
To investigate the impacts of infantile infection and antibiotic exposure on pediatric psoriasis development.
Methods |
This is a nationwide nested case-control study. From the National Health Insurance Research Database of Taiwan, a total of 1527 patients with pediatric psoriasis were identified and matched with 15,270 reference individuals without psoriasis, for the period of 2000 to 2017. Demographic characteristics and comorbidities were compared. Conditional stepwise logistic regression analysis was conducted to examine the associations.
Results |
The mean ages were 9.9 ± 3.7 years in both groups. Atopic dermatitis (adjusted odds ratio [aOR], 2.07; 95% confidence interval [CI], 1.84-2.32) and family history of psoriasis, especially of the mother (aOR, 9.86; 95% CI, 6.89-14.10) or other first-degree relatives (aOR, 5.49; 95% CI, 3.91-7.70), were independently associated with pediatric psoriasis on multivariate analyses. Skin viral and bacterial infections (aOR, 1.35; 95% CI, 1.13-1.62) and fungal infections (aOR, 1.71; 95% CI, 1.44-2.04) in the first 2 years of life were significantly associated with pediatric psoriasis. Systemic antibiotic exposure was not. These results were consistent at different time periods across sensitivity analyses.
Limitation |
Information about diet and lifestyle was not available.
Conclusion |
Skin infections at an early age were associated with pediatric psoriasis development.
Le texte complet de cet article est disponible en PDF.Key words : antibiotics, infantile, infection, microbiota, nested case-control study, pediatric psoriasis
Abbreviations used : aOR, CI, FDR, NHIRD, OR, Th
Plan
Drs Chen and Wu contributed equally to this article. |
|
Funding sources: Supported by Ministry of Science and Technology, Taiwan (MOST 104-2314-B-010-051 MY3 to Dr Chen) and Taichung Veterans General Hospital, Taiwan (TCVGH-1066802C to Dr Chen). |
|
IRB approval status: Reviewed and approved by Taipei Veterans General Hospital IRB (no. 2017-08-005CC) and Taichung Veterans General Hospital IRB (no. CE20224B). |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?